The majority of congressional Republicans have called for the Trump administration to end the practice of mail-in abortion pills.
In a letter sent to Secretary of Health and Human Services Robert F. Kennedy Jr. and Food and Drug Commissioner Marty Makary last week, 175 Republicans moved to “respectfully ask that the deleterious and grossly underreported effects on women of the drug mifepristone be aggressively investigated and decisive action taken to protect women from harm.” They further requested that the health officials “reinstate the in-person dispensing
requirement for mifepristone.”
“Furthermore, while we have long known that mifepristone causes the death by starvation of children alive in the womb—it is baby poison—we now know with greater certitude that their mothers are also being seriously harmed,” the letter adds.
The lawmakers go on to state that the Biden-era “mail-order scheme was designed to give abortion activists license to mail drugs everywhere.”
A similar letter was sent by U.S. Senators last month. “Unrestricted access to abortion pills is systematically undermining states’ rights and violating pro-life state laws,” the letter reads, adding, “The Biden-Harris administration enabled the deception of American women and the violation of states’ constitutional rights by relying on faulty data to claim that there would be no increase in complications if abortion drugs were approved for mail-order.”
Meanwhile, three attorneys general have filed a new challenge in their lawsuit against the abortion pill mifepristone, targeting the FDA’s approval of a generic version of the drug.
“Mifepristone is a high-risk drug that the FDA continues to green-light despite its devastating effects on pregnant women and girls. Studies of the real-world use of mifepristone concluded that significant morbidity and mortality have occurred following the use of mifepristone as an abortifacient,” the filing says, adding that the generic drug is “chemically identical to Danco’s Mifeprex and GenBioPro’s generic mifepristone.” It therefore brings the “same side effects, risks, and harms to pregnant women and girls as Mifeprex and GenBioPro.”
